Sonnet BioTherapeutics Provides Fiscal Year 2020 Business and Earnings Update
PRINCETON, NJ / ACCESSWIRE / December 17, 2020 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...
Day: December 17, 2020
TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System
FREDERICK, Md., Dec. 17, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection...
Intrivo Diagnostics Secures National Distribution Agreement with McKesson Medical-Surgical for Access Bio CareStart™ COVID-19 Tests
Additional agreement that expands Intrivo’s family of authorized distributors will ensure broad access to rapid testing solutions across USLOS ANGELES,...
Tarsier Pharma’s Positive End-of-Phase 2 Meeting with the U.S. FDA Sets Stage for TRS01 Phase III Program in Uveitis
TEL-AVIV, Israel, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Tarsier Pharma (doing business as Tarsius Pharma Ltd.), a late clinical stage...
Resonant Customers Surpass Shipment Milestone of 50 Million RF Filters Designed with Proprietary ISN® Technology
RF Filter Designs Shipped Covered 9 Different Cellular and Wi-Fi Bands Across Multiple Customers for Use in Mobile Handset, Infrastructure,...
Brain Scientific To Enter the U.S. Pediatric Market with NeuroCap™ for Children
The New Product Offering will Bring Advanced, Disposable EEG Technology to Pediatric Clinicians across the CountryNEW YORK, Dec. 17, 2020...
Cybin Inc. (NEO: CYBN) Acquisition, Three-Pillar Approach Reason for Optimistic MDD Outlook
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) today announces its placement in...
American Cannabis Company, Inc. Announces Executed Non-Binding Letter of Intent (LOI) for Strategic Acquisition in Southern Colorado
DENVER, CO, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”),...
Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data from Sweden
Authors report that celiprolol may have a protective effect in COL3A1-positive vEDS patients European Journal of Vascular and Endovascular Surgery:...
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed
SAN CARLOS, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions...
SELLAS Strengthens Year-End Balance Sheet with Addition of Approximately $30.5 Million
- Proceeds Received from Registered Direct Offering, Warrant Exercises and Upfront Fee from China Out-licensing - - Improved Cash Position...
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused...
Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer
CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying,...
CalciMedica Announces IDMC Recommendation to Continue with Trial Evaluating Auxora™ in Patients with Severe COVID-19 Pneumonia
Blinded placebo-controlled trial is expected to enroll more than 100 patients at U.S. clinical sites by end of DecemberThe Company...
Mersana Therapeutics to Host Virtual Analyst and Investor Event
CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and...
VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for FCD105 in Acne
Company on track to initiate the TRILOGY Phase 3 program in 2021BRIDGEWATER, N.J., Dec. 17, 2020 (GLOBE NEWSWIRE) -- VYNE...
Algernon Pharmaceuticals Provides Additional Information on Phase 2b/3 Ifenprodil COVID-19 Study Interim Data
VANCOUVER, British Columbia, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
ORYZON Launches Pioneering Schizophrenia Precision Medicine Study In Collaboration With Columbia Psychiatry
Goal is to characterize the neuropsychiatric symptoms of patients harboring disease-causing SETD1A gene mutationsAlso includes fundamental research in preclinical SETD1A...
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution
Application Assigned a PDUFA Date of August 6, 2021DEER PARK, Ill., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc....
Merus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab
UTRECHT, The Netherlands and STAMFORD, Conn., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company...